tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

APLIF Stock Latest News

Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
Company AnnouncementsAppili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
18d ago
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
PremiumCompany Announcements
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
1M ago
Appili Therapeutics Faces Termination of Agreement with Aditxt
PremiumCompany Announcements
Appili Therapeutics Faces Termination of Agreement with Aditxt
2M ago
Aditxt announces termination of arrangement agreement with Appili Therapeutics
PremiumThe Fly
Aditxt announces termination of arrangement agreement with Appili Therapeutics
2M ago
ADTX
Appili Therapeutics Advances Tularemia Vaccine Research
PremiumCompany Announcements
Appili Therapeutics Advances Tularemia Vaccine Research
2M ago
Appili Therapeutics publishes manuscript on emergency response to tularemia
PremiumThe FlyAppili Therapeutics publishes manuscript on emergency response to tularemia
2M ago
Appili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
Premium
Company Announcements
Appili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
3M ago
Appili Therapeutics granted new patents for LIKMEZ
Premium
The Fly
Appili Therapeutics granted new patents for LIKMEZ
3M ago
Appili Therapeutics CEO to Discuss Strategic Growth and Funding Initiatives
PremiumCompany Announcements
Appili Therapeutics CEO to Discuss Strategic Growth and Funding Initiatives
3M ago
Appili Therapeutics CEO to join Aditxt CEO for weekly update on April 4
PremiumThe Fly
Appili Therapeutics CEO to join Aditxt CEO for weekly update on April 4
3M ago
ADTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
PLX
SLS
Appili Therapeutics Seeks $117.5 Million in Federal Funding for Infectious Disease Treatments
PremiumCompany Announcements
Appili Therapeutics Seeks $117.5 Million in Federal Funding for Infectious Disease Treatments
4M ago
Appili Therapeutics announces submission of government funding proposals
PremiumThe FlyAppili Therapeutics announces submission of government funding proposals
4M ago
Appili Therapeutics expects Aditxt transaction to close in Q1
Premium
The Fly
Appili Therapeutics expects Aditxt transaction to close in Q1
4M ago
ADTX
Appili Therapeutics Advances Pipeline with Strong Shareholder and Government Support
Premium
Company Announcements
Appili Therapeutics Advances Pipeline with Strong Shareholder and Government Support
5M ago
Appili Therapeutics Moves Forward with Aditxt Acquisition
PremiumCompany Announcements
Appili Therapeutics Moves Forward with Aditxt Acquisition
8M ago
Appili Therapeutics Highlights Progress and Shareholder Support
PremiumCompany Announcements
Appili Therapeutics Highlights Progress and Shareholder Support
8M ago
Appili Therapeutics reports Q2 EPS (C$0.01) vs. (C$0.01) last year
PremiumThe Fly
Appili Therapeutics reports Q2 EPS (C$0.01) vs. (C$0.01) last year
8M ago
Appili Therapeutics shareholders vote in favor of Aditxt transaction
PremiumThe Fly
Appili Therapeutics shareholders vote in favor of Aditxt transaction
8M ago
ADTX
Appili Shareholders Approve Acquisition by Aditxt
PremiumCompany AnnouncementsAppili Shareholders Approve Acquisition by Aditxt
8M ago
Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
Premium
The Fly
Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
9M ago
ADTX
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition
Premium
Company Announcements
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >